ethyl 3-methyl-4-(α-D-galactopyranosyl)butyrate | 439686-91-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: ethyl 3-methyl-4-(α-D-galactopyranosyl)butyrate
• 英文别名: ethyl 3-methyl-4-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]butanoate
• CAS: 439686-91-6
• 化学式: C₁₃H₂₄O₇
• 分子量: 292.329
• InChiKey: JTCMDPJGTRKYHW-OAGSIOMDSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.7
• 重原子数：
  20
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.92
• 拓扑面积：
  116
• 氢给体数：
  4
• 氢受体数：
  7

文献信息

• C-glycoside compounds for stimulating the synthesis of glycosaminoglycans
  申请人：SOCIETE L'OREAL S.A.

  公开号：US20040048785A1

  公开（公告）日：2004-03-11

  C-glycoside compounds are suited for stimulating the synthesis of glycosaminoglycans containing a D-glucosamine and/or N-acetyl-D-glucosamine residue, advantageously hyaluronic acid, and/or proteoglycans, advantageously proteoglycans containing hyaluronic acid, by fibroblasts and/or keratinocytes.

  C-糖苷化合物适合刺激成纤维细胞和/或角质形成细胞合成含有D-葡萄糖胺和/或N-乙酰-D-葡萄糖胺残基的糖胺聚糖，优选透明质酸和/或蛋白聚糖，优选含有透明质酸的蛋白聚糖的合成。
• COSMETIC USE OF A C-GLYCOSIDE DERIVATIVE IN COMBINATION WITH ASCORBIC ACID
  申请人：Pineau Nathalie

  公开号：US20090274638A1

  公开（公告）日：2009-11-05

  The present invention relates to a cosmetic use of a synergistic combination of at least one C-glycoside derivative with at least ascorbic acid, or one of its derivatives or analogs, for preventively or curatively treating the signs of aging of body or facial skin, irrespective of whether they are chronobiological or photoinduced.

  本发明涉及利用至少一种C-糖苷衍生物与至少抗坏血酸或其衍生物或类似物的协同组合在化妆品中的应用，用于预防或治疗身体或面部皮肤的衰老迹象，无论它们是生物钟性还是光致导致的。
• USE OF A GALACTOSE-DERIVED C-GLYCOSIDE COMPOUND AS AN AGENT FOR ACTIVATING AND REGULATING CUTANEOUS IMMUNITY
  申请人：L'Oréal

  公开号：EP2007746A1

  公开（公告）日：2008-12-31
• USE OF C-GLYCOSIDE DERIVATIVES AS PRO-DESQUAMATING ACTIVE AGENTS
  申请人：L'Oreal

  公开号：EP2051690A2

  公开（公告）日：2009-04-29
• Composition combining a C-glycoside derivative and an emulsifying polymer
  申请人：Simonnet Jean-Thierry

  公开号：US20080003191A1

  公开（公告）日：2008-01-03

  The present invention relates to a cosmetic and/or dermatological composition comprising, in a physiologically acceptable medium, at least one C-glycoside derivative and at least one emulsifying polymer chosen from polyolefins containing polar portion(s) and amphiphilic polymers comprising at least one acrylamido-2-methylpropanesulfonic acid (AMPS) unit.